Westfield Capital Management CO LP Seagen Inc. Transaction History

Westfield Capital Management CO LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $59.8 Million - $78.9 Million	-499,769 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$142.57 - $190.86 $3.76 Million - $5.03 Million	26,379 Added 5.57%	499,769 $77.3 Million
Q3 2021 Nov 12, 2021	SELL	$142.45 - $169.82 $5.87 Million - $7 Million	-41,200 Reduced 8.01%	473,390 $80.4 Million
Q2 2021 Aug 10, 2021	SELL	$135.08 - $161.1 $526,541 - $627,967	-3,898 Reduced 0.75%	514,590 $81.2 Million
Q1 2021 May 14, 2021	SELL	$137.51 - $190.8 $2.94 Million - $4.08 Million	-21,377 Reduced 3.96%	518,488 $72 Million

Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $88.9 Million - $114 Million	539,865 New	539,865 $94.6 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

Stay updated on Westfield Capital Management CO LP with notifications on news.